RxDoctor Payments Data

Mauricio Villavicencio, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Rochester, MNNPI 1497153332

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (59.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by Edwards Lifesciences at 59.0% of the total. Reporting peaked in 2020 at $3,482 and has fallen 95.4% since, to $160 in 2024.

$4,070in general payments, 2019–2025

Across 15 payments — averaging $271.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$2K
  • Medtronic$1K
  • Abbott$304
  • Paragonix Technologies, Inc.$160
$334,657in research payments, 2019–2025

Across 32 payments — averaging $10,458 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Transmedics, Inc.$335K

What the payments were for

  • Speaking & faculty fees$2,40059%
  • Travel & lodging$78619%
  • Food & beverage$88422%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences2$2,400
Medtronic8$1,206
Abbott2$304
Paragonix Technologies, Inc.3$160

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,070 in reported general payments places this provider in the 60th percentile of 128 thoracic surgery (cardiothoracic vascular surgery) providers in Minnesota.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Minnesota

Medicare billing

Part B allowed, 2024
$170,196
Medicare patients
79
Services billed
218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →